Clinerion Ltd Contact Details:
Main address: Margarethenstrasse 47 4053 Basel, Switzerland ,
Tel:+41 61 865 60 60 , E-mail: info(at) Website:

Clinerion Patient Network Explorer

Clinerion Patient Network Explorer

Optimized study design, precise site selection and faster patient search and identification for clinical research - in real time.

Clinerion Cookie Policy

Welcome to the Clinerion website. This website uses cookies. These cookies are used on your browser to understand how you are using our website. Using this website means you agree to our use of cookies. If you prefer not to have these cookies on your device, we advise you to disable them in your web browser settings. You accept the use of cookies by accepting this notice. You can read more details via our Privacy Policy page.

Privacy Policy page >

Improving Patient Outcomes with Real World Evidence

One year ago, the US FDA finalized its guidance on the use of electronic health records in clinical studies, to advance the use of RWE for regulatory decision-making.

22.08.2019, Basel, Switzerland

Over subsequent months, the agency launched a brace of RWE initiatives, including a $100 M project to collect RWE data from 10 M individuals, an app for the collection of real-world data (RWD), partnerships for cancer research using RWE, and, most crucially, their 2019 strategic Framework on the use of RWD and RWE.

RWE as more than a "valuable complement"

What this demonstrates is, as more patient data is digitized and as more evidence is collected on RWE itself, that the value of RWE in generating insights into a drug’s impact on patient journeys and outcomes is now fully accepted and beginning to be actionable.

Besides being a valuable complement to evidence from traditional randomized controlled trials, RWE can support assessments of treatment patterns, costs and outcomes of interventions, identify underserved therapeutic areas, and assess efficacy or safety of therapies in real-world use. In particular, RWE can be used to design efficient trials, support market access activities and inform reimbursement decisions.

Supporting the next generation of clinical researchers

Clinerion supports improving patient outcomes via real world evidence. Today, our Patient Network Explorer offers analytics based on de-identified real-world data from 20 million patients around the world from our global network of partner hospitals.

We are excited to “pay it forward” and support the development of the next generation of clinical researchers.

To this end, Clinerion is partnering with Dresden International University to offer their Master’s in Clinical Research students access to a subset of our real-world data.

These students will gain unprecedented insights and generate valuable, actionable real-world evidence through the use of our real-time, real-world data in their research.  We look forward to the world of advances in learning that will arise from these clinicians and investigators of the future!

Read more about our new RWE initiative with Dresden International University >

Read our interview with clinical expert Keyla Deucher on how RWE can support Clinical Development and Patient Centricity >

Looking for "the right patient, for the right trial, at the right time"?

Contact us.

Personal Data Protection Statement

The information you provide allows us to provide you with information and updates on Clinerion’s products and services (the purpose). By submitting your details in this form, you give explicit consent that your personal details may be used for this and only this purpose by Clinerion.

Clinerion, as the data controller and processor, will maintain the data for as long as the data is required for the purposes mentioned above, or until you withdraw consent as stated below. Personal data are not kept longer than necessary and are processed in a manner that ensures appropriate security and confidentiality, including for preventing unauthorized access to or use of personal data and the equipment used for the processing.

We will not sell or give away any personal information that you provide and only use it for the purposes stated above. You may request to view, correct, or delete your data in Clinerion’s database or withdraw consent by contacting Please note that withdrawal of consent shall not affect the lawfulness of Clinerion’s use of your personal data for the purposes mentioned above before withdrawal of consent.

The legal address of Clinerion: Clinerion Ltd, Elisabethenanlage 11, 4051 Basel, Switzerland. e-Mail address

News / Events / Webinars